Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
988
datasets available to search
ShareScore release 0.9.0
Dataset results
988 results for “platinum”
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-30
ClinicalTrials.gov study NCT05281471. IPD Sharing: NO. Countries: 1. Publications: 4.
Phase II Study DCVAC/OvCa Plus Carboplatin Gemcitabine Relapsed Platinum (Pt)-Sensitive Epithelial Ovarian Carcinoma
ClinicalTrials.gov study NCT02107950. IPD Sharing: YES. Countries: 3. Publications: 1.
TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer
ClinicalTrials.gov study NCT00102973. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Escalating Dose I.P. Platinum for Gastrointestinal Peritoneal Carcinomatosis
ClinicalTrials.gov study NCT00001332. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Evaluation of ABEMACICLIB Monotherapy in Patients With Locally Advanced/Metastatic Head and Neck Cancer After Failure of Platinum and Cetuximab or Anti-EGFR-based Therapy and Harboring an Homozygous D
ClinicalTrials.gov study NCT03356223. IPD Sharing: Not stated. Countries: 1. Publications: 14.
A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer.
ClinicalTrials.gov study NCT00191607. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Real-World Effectiveness of Bevacizumab Based on AURELIA in Platinum-resistant Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT03367182. IPD Sharing: NO. Countries: 1. Publications: 1.
Weekly Paclitaxel With or Without Pazopanib in Platinum Resistant or Refractory Ovarian Cancer
ClinicalTrials.gov study NCT01644825. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Oregovomab and PLD in PARP Inhibitor Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients Not Candidate for Platinum Retreatment
ClinicalTrials.gov study NCT05407584. IPD Sharing: NO. Countries: 1. Publications: 1.
Niraparib as Maintenance Therapy in Patients With Platinum Sensitive Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT04546373. IPD Sharing: Not stated. Countries: 1. Publications: 1.
MITO 35B: Olaparib Beyond Progression Compared to Platinum Chemotherapy After Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer Patients.
ClinicalTrials.gov study NCT05255471. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Iron and platinum experiments raw data
<p>All the raw data from the voltage dividers, electrical current sensors, and streak cameras used in the calculations of resistivity limits and penetration depths measurements for the gas metals of Iron and Platinum.</p>
Characterization of platinum(II) complexes exhibiting inhibitory activity against 20S Proteasome
<p><span>Proteasome inhibitors are useful for biochemical research and clinical treatment. In our previous study, we reported that the 4N-coordinated platinum complexes with anthracene and heterocycle exhibited proteasome inhibitory activity. In the present study, the structure-activity relationships and characterization of these complexes were determined for elucidation of role of aromatic ligands. Lineweaver-Burk analysis revealed that the chemical structure of heterocyles affects binding mode of platinum complexes. Platinum complexes with anthracene and pyridine showed competitive inhibition although platinum complexes with antharcene and phenantholine showed non-competitive inhibition. The structure-activity relationships demonstrated that anthracene moiety play a crucial role for proteasome inhibitory activity. The platinum complexes with naphthalene or benzene exhibited lower inhibitory activities than the platinum complex with anthracene. The reactivity with N-acetyl cysteine varied according to the chemical structure of complexes. </span></p>
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
ClinicalTrials.gov study NCT06787612. IPD Sharing: YES. Countries: 4. Publications: 0.
Durvalumab and Tremelimumab With Platinum-based Chemotherapy in Intrahepatic Cholangiocarcinoma (ICC)
ClinicalTrials.gov study NCT04989218. IPD Sharing: NO. Countries: 1. Publications: 0.
BRCA 1/2 Status as a Predictive Factor to Response to Platinum Based Chemotherapy in Cancer Ovary
ClinicalTrials.gov study NCT06304922. IPD Sharing: Not stated. Countries: 0. Publications: 11.
Study of Maplirpacept (PF-07901801) in Combination With PLD in Patients With Platinum-Resistant Ovarian Cancer
ClinicalTrials.gov study NCT05261490. IPD Sharing: YES. Countries: 1. Publications: 0.
A Phase II, Study to Determine the Preliminary Efficacy of Novel Combinations of Treatment in Patients With Platinum Refractory Extensive-Stage Small-Cell Lung Cancer
ClinicalTrials.gov study NCT02937818. IPD Sharing: YES. Countries: 5. Publications: 0.
Dose Dense Paclitaxel With Pembrolizumab (MK-3475) in Platinum Resistant Ovarian Cancer
ClinicalTrials.gov study NCT02440425. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Navicixizumab in Patients With Platinum Resistant Ovarian Cancer
ClinicalTrials.gov study NCT05043402. IPD Sharing: NO. Countries: 0. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.